These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 24081978

  • 1. A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phases.
    Yano S, Tazawa H, Hashimoto Y, Shirakawa Y, Kuroda S, Nishizaki M, Kishimoto H, Uno F, Nagasaka T, Urata Y, Kagawa S, Hoffman RM, Fujiwara T.
    Clin Cancer Res; 2013 Dec 01; 19(23):6495-505. PubMed ID: 24081978
    [Abstract] [Full Text] [Related]

  • 2. Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus.
    Bach P, Abel T, Hoffmann C, Gal Z, Braun G, Voelker I, Ball CR, Johnston IC, Lauer UM, Herold-Mende C, Mühlebach MD, Glimm H, Buchholz CJ.
    Cancer Res; 2013 Jan 15; 73(2):865-74. PubMed ID: 23293278
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic Cell-Cycle-Decoy Efficacy of a Telomerase-Dependent Adenovirus in an Orthotopic Model of Chemotherapy-Resistant Human Stomach Carcinomatosis Peritonitis Visualized With FUCCI Imaging.
    Yano S, Takehara K, Tazawa H, Kishimoto H, Urata Y, Kagawa S, Fujiwara T, Hoffman RM.
    J Cell Biochem; 2017 Nov 15; 118(11):3635-3642. PubMed ID: 27171483
    [Abstract] [Full Text] [Related]

  • 4. Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging.
    Yano S, Takehara K, Zhao M, Tan Y, Han Q, Li S, Bouvet M, Fujiwara T, Hoffman RM.
    Cell Cycle; 2016 Jul 02; 15(13):1715-23. PubMed ID: 27152859
    [Abstract] [Full Text] [Related]

  • 5. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
    Yamasaki Y, Tazawa H, Hashimoto Y, Kojima T, Kuroda S, Yano S, Yoshida R, Uno F, Mizuguchi H, Ohtsuru A, Urata Y, Kagawa S, Fujiwara T.
    Eur J Cancer; 2012 Sep 02; 48(14):2282-91. PubMed ID: 22244827
    [Abstract] [Full Text] [Related]

  • 6. Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses.
    Friedman GK, Moore BP, Nan L, Kelly VM, Etminan T, Langford CP, Xu H, Han X, Markert JM, Beierle EA, Gillespie GY.
    Neuro Oncol; 2016 Feb 02; 18(2):227-35. PubMed ID: 26188016
    [Abstract] [Full Text] [Related]

  • 7. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
    Rutella S, Bonanno G, Procoli A, Mariotti A, Corallo M, Prisco MG, Eramo A, Napoletano C, Gallo D, Perillo A, Nuti M, Pierelli L, Testa U, Scambia G, Ferrandina G.
    Clin Cancer Res; 2009 Jul 01; 15(13):4299-311. PubMed ID: 19509143
    [Abstract] [Full Text] [Related]

  • 8. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabrò E, Pastorino U, Sozzi G.
    Proc Natl Acad Sci U S A; 2009 Sep 22; 106(38):16281-6. PubMed ID: 19805294
    [Abstract] [Full Text] [Related]

  • 9. Real-Time Fluorescence Image-Guided Oncolytic Virotherapy for Precise Cancer Treatment.
    Yano S, Tazawa H, Kishimoto H, Kagawa S, Fujiwara T, Hoffman RM.
    Int J Mol Sci; 2021 Jan 17; 22(2):. PubMed ID: 33477279
    [Abstract] [Full Text] [Related]

  • 10. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L, Lai D, Liu T, Cheng W, Guo L.
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep 17; 42(9):593-602. PubMed ID: 20705681
    [Abstract] [Full Text] [Related]

  • 11. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B, Jimi S, Kondo T, Naganuma Y, Matsumoto T, Kuroki M, Iwasaki H, Emoto M.
    Stem Cells; 2011 Oct 17; 29(10):1485-95. PubMed ID: 21919130
    [Abstract] [Full Text] [Related]

  • 12. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A, Liguori E, Pirozzi G, Tirino V, Compare D, Franco R, Tatangelo F, Palaia R, D'Armiento FP, Pollastrone G, Affuso A, Bottazzi EC, Masone S, Persico G, Nardone G.
    J Cell Physiol; 2012 Jun 17; 227(6):2686-93. PubMed ID: 21898409
    [Abstract] [Full Text] [Related]

  • 13. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
    Watanabe T, Hioki M, Fujiwara T, Nishizaki M, Kagawa S, Taki M, Kishimoto H, Endo Y, Urata Y, Tanaka N, Fujiwara T.
    Exp Cell Res; 2006 Feb 01; 312(3):256-65. PubMed ID: 16356494
    [Abstract] [Full Text] [Related]

  • 14. Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy.
    Yano S, Zhang Y, Zhao M, Hiroshima Y, Miwa S, Uehara F, Kishimoto H, Tazawa H, Bouvet M, Fujiwara T, Hoffman RM.
    Cell Cycle; 2014 Feb 01; 13(24):3958-63. PubMed ID: 25483077
    [Abstract] [Full Text] [Related]

  • 15. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
    Ma HI, Chiou SH, Hueng DY, Tai LK, Huang PI, Kao CL, Chen YW, Sytwu HK.
    J Neurosurg; 2011 Mar 01; 114(3):651-62. PubMed ID: 21054139
    [Abstract] [Full Text] [Related]

  • 16. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
    Zhang J, Luo N, Luo Y, Peng Z, Zhang T, Li S.
    Int J Oncol; 2012 Mar 01; 40(3):747-56. PubMed ID: 22025269
    [Abstract] [Full Text] [Related]

  • 17. Methioninase Cell-Cycle Trap Cancer Chemotherapy.
    Hoffman RM, Yano S, Igarashi K.
    Methods Mol Biol; 2019 Mar 01; 1866():133-148. PubMed ID: 30725413
    [Abstract] [Full Text] [Related]

  • 18. Antitumor effects of telomerase-specific replication-selective oncolytic viruses for adenoid cystic carcinoma cell lines.
    Sato D, Kurihara Y, Kondo S, Shirota T, Urata Y, Fujiwara T, Shintani S.
    Oncol Rep; 2013 Dec 01; 30(6):2659-64. PubMed ID: 24065118
    [Abstract] [Full Text] [Related]

  • 19. Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells.
    Watanabe Y, Hashimoto Y, Kagawa S, Kawamura H, Nagai K, Tanaka N, Urata Y, Fujiwara T.
    Cancer Gene Ther; 2012 Nov 01; 19(11):767-72. PubMed ID: 22956040
    [Abstract] [Full Text] [Related]

  • 20. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS, Jeong YJ, Jeong SH, Heo HJ, Kim HK, Bae KB, Park YH, Kim SU, Kim JM, Kim N, Ko KS, Rhee BD, Han J.
    Gastroenterology; 2015 Oct 01; 149(4):1006-16.e9. PubMed ID: 26091938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.